The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


Erratum for Visvanathan et al., J Immunol 165 (4) 2258-2262.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McNeil, H. P.
Right arrow Articles by Harmer, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McNeil, H. P.
Right arrow Articles by Harmer, J. A.
The Journal of Immunology, 2002, 169: 1135.
Copyright © 2002 by The American Association of Immunologists, Inc.

Retraction: Monocyte Tissue Factor Induction by Activation of beta2-Glycoprotein-I-Specific T Lymphocytes Is Associated with Thrombosis and Fetal Loss in Patients with Antiphospholipid Antibodies

H. Patrick McNeil, Carolyn L. Geczy and Jason A. Harmer

We wish to withdraw the results of the paper by Sudha Visvanathan, Carolyn L. Geczy, Jason A. Harmer, and H. Patrick McNeil, "Monocyte Tissue Factor Induction by Activation of beta2-Glycoprotein-I-Specific T Lymphocytes Is Associated with Thrombosis and Fetal Loss in Patients with Antiphospholipid Antibodies," The Journal of Immunology 2000;165:2258–2262. The first author of the original manuscript, Sudha Visvanathan, has declined to sign the correction letter.

In the above article, we reported that blood mononuclear cells from patients with the antiphospholipid syndrome (APS) expressed high levels of tissue factor (TF) when stimulated with plasma-purified beta2-glycoprotein-I (beta2GPI) in vitro, whereas little or no TF was induced when blood from patients without the APS or healthy controls was tested. Subsequent experiments using recombinant beta2GPI and a range of different preparations of purified beta2GPI have shown much more variable and less consistent results than those we reported. After extensive testing, we feel that differences are unlikely to be due to contaminating endotoxin in some of the preparations. Although an explanation for the discrepancy remains unclear, we can no longer conclude that beta2GPI is the cause of the observed TF induced on mononuclear cells from patients with APS, and for this reason, we wish to withdraw the results reported in this manuscript.

H. Patrick McNeil

Inflammation Research Unit

School of Medical Sciences

University of New South Wales

Sydney, Australia

Carolyn L. Geczy

Jason A. Harmer

Cytokine Research Unit

School of Medical Sciences

University of New South Wales

Sydney, Australia





This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McNeil, H. P.
Right arrow Articles by Harmer, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McNeil, H. P.
Right arrow Articles by Harmer, J. A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS